Medicines Safety Update
Medicines Safety Update
About this item
Full title
Medicines Safety Update
Publisher
Melbourne: Therapeutic Guidelines Limited
Journal title
Australian prescriber, 2012-12, Vol.35 (6), p.168
Language
English
Formats
Publication information
Publisher
Melbourne: Therapeutic Guidelines Limited
Subjects
More information
Scope and Contents
Contents
Dosing with all formulations should be as described in the approved Product Information (PI).2 Patients should be assessed for QTc interval prolongation or cardiac arrhythmia before being prescribed ondansetron Avoid ondansetron in patients with congenital long QT syndrome Caution should be exercised when prescribing for patients who have or may de...
Alternative Titles
Full title
Medicines Safety Update
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2680201272
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2680201272
Other Identifiers
ISSN
0312-8008
E-ISSN
1839-3942
How to access this item
Log in as a Library member
